This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
over 18
years old
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

The purpose of this study is to determine whether one dose of denosumab can lead to changes in the tumor, which may decrease the ability of tumor to spread.

Provided treatments

  • Biological: denosumab
  • Procedure: Surgery

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02900469. The sponsor of the trial is NYU Langone Health and it is looking for 44 volunteers for the current phase.
Official trial title:
Pre-surgical Evaluation of Denosumab in Patients With Operable Invasive Breast Cancer